BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12431205)

  • 1. Virus-specific antibody titres in different phases of hepatitis C virus infection.
    Nikolaeva LI; Blokhina NP; Tsurikova NN; Voronkova NV; Miminoshvili MI; Braginsky DM; Yastrebova ON; Booynitskaya OB; Isaeva OV; Michailov MI; Archakov AI
    J Viral Hepat; 2002 Nov; 9(6):429-37. PubMed ID: 12431205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C.
    Quinti I; Hassan NF; El Salman D; Shalaby H; El Zimatty D; Monier MK; Arthur RR
    J Hepatol; 1995 Dec; 23(6):640-7. PubMed ID: 8750161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response in Japanese acute hepatitis patients with hepatitis C virus infection.
    Yamaguchi N; Tokushige K; Yamauchi K; Hayashi N
    Can J Gastroenterol; 2000; 14(7):593-8. PubMed ID: 10978946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
    Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
    Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
    Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
    Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
    Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of IgM anti-HCV core level in chronic hepatitis C.
    Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
    J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
    Löhr H; Nagel C; Dienes HP; Simpson B; Michel G; Goergen B; Meyer zum Büschenfelde KH; Gerken G
    Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
    Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
    J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
    Kanno A; Kazuyama Y
    J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of IgM response in hepatitis C virus infection.
    Zaaijer HL; Mimms LT; Cuypers HT; Reesink HW; van der Poel CL; Taskar S; Lelie PN
    J Med Virol; 1993 Jul; 40(3):184-7. PubMed ID: 7689091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies to different virus antigens in patients with chronic hepatitis C].
    Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.